Clinical Trials in Baltimore

Showing 8261-8280 of 23,476 trials

Pilot Study of reSET-O to Treatment-as-usual in Acute Care Settings

NCT04817267

This randomized controlled pilot study will evaluate feasibility, acceptability, and potential efficacy of an app, reSET-O, for patients being started on buprenorphine in acute care settings.

Opioid-use Disorder

Johns Hopkins University8 participantsStarted Mar 2022

Baltimore, Maryland, United States

COMPLETEDPhase 1< 1 mile

Study to Evaluate the Safety of a New Oxime, MMB4 DIMETHANESULFONATE (DMS)

NCT02018250

This clinical study will evaluate escalating dosages of MMB4 DMS to determine its safety when delivered intramuscularly (i.m.) to the anterior thigh.

Safety and Efficacy

U.S. Army Medical Research and Development Command32 participantsStarted Mar 2012

Baltimore, Maryland, United States

COMPLETEDPhase 3< 1 mile

Diuretic Comparison Project

NCT02185417

The Diuretic Comparison Project aimed to evaluate whether chlorthalidone, as compared with hydrochlorothiazide, would reduce the risk of major nonfatal cardiovascular disease outcomes and non-cancer-related deaths in older patients with hypertension who were receiving hydrochlorothiazide at baseline. The investigators incorporated the pragmatic methods used by the Department of Veterans Affairs (VA) Healthcare System to provide a real-world assessment of the effectiveness of chlorthalidone as compared with hydrochlorothiazide in routine clinical care.

Hypertension

VA Office of Research and Development20,723 participantsStarted Jun 2016

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Fayetteville, Arkansas, United States +67 more locations

Pilot Study of reSET-O to Treatment-as-usual in Acute Care Settings

Study to Evaluate the Safety of a New Oxime, MMB4 DIMETHANESULFONATE (DMS)

Diuretic Comparison Project

Find Trials by Condition in Baltimore

Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients

Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine

A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration

A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss

Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation

Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta Hepatitis

Safety and Efficacy Study of TNX-102 SL in Patients With Military-related PTSD

Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia

Use of Oxandrolone to Promote Growth in Infants With HLHS

Nexplanon Use in Women Primarily Choosing a Combined Oral Contraceptive

A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2

HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia

Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors

Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients

An Exploratory Study of the Effects of Nivolumab Combined With Ipilimumab in Patients With Treatment-Naive Stage IV or Recurrent Non-Small Cell Lung Cancer (NSCLC)

Clinical Trial to Evaluate the Efficacy of Gene Therapy for Pyruvate Kinase Deficiency